162 related articles for article (PubMed ID: 2470093)
1. Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene.
Yarden Y; Weinberg RA
Proc Natl Acad Sci U S A; 1989 May; 86(9):3179-83. PubMed ID: 2470093
[TBL] [Abstract][Full Text] [Related]
2. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
3. Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
Reardon DB; Hung MC
J Biol Chem; 1993 Aug; 268(24):18136-42. PubMed ID: 7688739
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
[TBL] [Abstract][Full Text] [Related]
5. Repression of neu-induced clonogenicity by dimethylsulfoxide correlates with decreased levels of neu-encoded cell-surface p185 and changes in phosphotyrosine content of endogenous proteins.
Matin A; Hung MC
Cancer Lett; 1993 Jan; 68(1):55-60. PubMed ID: 7678546
[TBL] [Abstract][Full Text] [Related]
6. Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene.
Boccaccio C; Gaudino G; Cilli M; Mondino A; Comoglio PM
Growth Factors; 1991; 5(3):233-42. PubMed ID: 1685656
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a neu/c-erbB-2 protein-specific activating factor.
Dobashi K; Davis JG; Mikami Y; Freeman JK; Hamuro J; Greene MI
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8582-6. PubMed ID: 1717981
[TBL] [Abstract][Full Text] [Related]
8. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
Stern DF; Heffernan PA; Weinberg RA
Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
[TBL] [Abstract][Full Text] [Related]
9. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro.
Cao H; Decker S; Stern DF
Oncogene; 1991 May; 6(5):705-11. PubMed ID: 1675782
[TBL] [Abstract][Full Text] [Related]
10. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.
Bargmann CI; Weinberg RA
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5394-8. PubMed ID: 2899890
[TBL] [Abstract][Full Text] [Related]
11. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
Connelly PA; Stern DF
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6054-7. PubMed ID: 1974718
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.
Stern DF; Kamps MP; Cao H
Mol Cell Biol; 1988 Sep; 8(9):3969-73. PubMed ID: 2464744
[TBL] [Abstract][Full Text] [Related]
13. The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS
Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
[TBL] [Abstract][Full Text] [Related]
14. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.
Stancovski I; Peles E; Ben Levy R; Lemprecht R; Kelman Z; Goldman-Michael R; Hurwitz E; Bacus S; Sela M; Yarden Y
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):95-103. PubMed ID: 1356018
[TBL] [Abstract][Full Text] [Related]
16. Receptor-like oncogenes: functional analysis through novel experimental approaches.
Yarden Y
Mol Immunol; 1990 Dec; 27(12):1319-24. PubMed ID: 1980338
[TBL] [Abstract][Full Text] [Related]
17. Biochemical analysis of the ligand for the neu oncogenic receptor.
Yarden Y; Peles E
Biochemistry; 1991 Apr; 30(14):3543-50. PubMed ID: 1672825
[TBL] [Abstract][Full Text] [Related]
18. Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock.
King CR; Borrello I; Porter L; Comoglio P; Schlessinger J
Oncogene; 1989 Jan; 4(1):13-8. PubMed ID: 2464783
[TBL] [Abstract][Full Text] [Related]
19. A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
Tarakhovsky A; Zaichuk T; Prassolov V; Butenko ZA
Oncogene; 1991 Dec; 6(12):2187-96. PubMed ID: 1685016
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
